CapsCanada Rebrands as Lyfe Group, Unifying for Global Expansion

DANIA BEACH, Fla. – May 07, 2026 – In a significant strategic move, CapsCanada, a cornerstone of the pharmaceutical and nutraceutical supply chain for over four decades, announced today its transition to a new corporate identity: Lyfe Group. The change unifies the company's extensive North and South American operations under a single, cohesive brand, positioning it for accelerated growth and enhanced clarity in the global drug delivery market.

Company officials emphasized that the rebranding is a deliberate strategic evolution, not the result of a merger or acquisition. It aims to consolidate the firm's identity as its operational footprint and product portfolio continue to expand, ensuring that its long-standing reputation for quality and reliability is clearly represented across all regions. The transition promises seamless continuity for its global customer base, with all product quality, manufacturing standards, and supply chain operations remaining unchanged.

A Legacy Reimagined for Global Scale

For more than 40 years, CapsCanada built its name on a foundation of manufacturing expertise, regulatory excellence, and deep customer relationships, all guided by a three-generation family legacy. The evolution to Lyfe Group represents the next chapter in this story, transforming a respected name into a unified global brand.

The strategic rationale behind the move is to create a singular identity that reflects the company's current scale and future ambitions. By consolidating its Americas operations, Lyfe Group aims to eliminate regional brand confusion, strengthen its overall market position, and create a scalable platform for sustained growth. This unification is designed to better communicate the company's comprehensive capabilities, from high-quality empty capsules to advanced oral dosage-form solutions.

"Becoming Lyfe Group is the natural next step in our journey," said Jonathan Gilinski, Executive Director of Lyfe Group, in a statement. "For more than 40 years, CapsCanada's reliability and reputation has been built on quality products, a reliable supply chain, excellent technical service, and the depth of our customer relationships. This transition brings all of that together under a unified identity that reflects the full scope of who we are today and the ambition of where we are going. We are proud of our legacy as CapsCanada, and we are excited to write the next chapter as Lyfe Group."

Investing in a Competitive Market

The rebranding is not just a change in name but the culmination of years of strategic investment aimed at bolstering its competitive edge. The global empty capsules market, valued at over $3.2 billion in 2026 and projected to grow at a CAGR of nearly 8%, is fiercely competitive, with major players like Lonza and ACG continually innovating. Lyfe Group's recent capital expenditures demonstrate its commitment to leading, not just participating, in this dynamic sector.

A cornerstone of this investment strategy was the major expansion of its flagship K-CAPS® HPMC vegetarian capsule manufacturing in Windsor, Ontario. Following earlier investments, a $28 million project significantly increased the facility's footprint and boosted capsule output by 50%, responding to the surging global demand for plant-based alternatives. This focus on HPMC (hydroxypropyl methylcellulose) capsules has positioned the company at the forefront of the shift away from traditional gelatin-based products.

Complementing its manufacturing prowess, the company recently relocated its distribution headquarters to a new 130,000-square-foot, state-of-the-art facility in Dania Beach, Florida. This move was engineered to optimize logistics, increase the global supply capacity for its products, and shorten lead times for its pharmaceutical and nutraceutical clients across more than 60 countries.

Innovation at the Core of the New Identity

Central to Lyfe Group's strategy is a relentless focus on product innovation that meets the evolving needs of formulators and consumers. The company's portfolio is anchored by its K-CAPS®, renowned for their performance on automatic filling machines, low moisture content ideal for sensitive ingredients, and extensive certifications, including Non-GMO, Kosher, and Halal.

Building on this success, Lyfe Group is expanding its offerings with two new cutting-edge products: K-CAPS® Natural Colorant Capsules and K-CAPS® Delayed Release Capsules. The introduction of natural colorant options directly addresses the powerful consumer-driven trend toward "clean label" products, allowing brands to deliver visually appealing supplements without synthetic additives.

The launch of delayed-release capsules taps into another critical market need. These functional capsules are engineered to bypass the stomach's acidic environment, protecting sensitive ingredients like probiotics and enzymes until they reach the intestines for optimal absorption. With the market for such modified-release capsules projected to grow at a CAGR of over 8.8%, this innovation ensures Lyfe Group is providing solutions for some of the most advanced formulations in the health and wellness industry.

The Path Forward as Lyfe Group

The Lyfe Group brand will be rolled out progressively throughout 2026. The company has been proactive in its messaging, assuring customers and partners that the transition will be smooth, with the same teams, technical service, and unwavering commitment to quality they have always relied on. The new name itself, Lyfe Group, is intended to embody the company's greater purpose: "to enhance the quality of life through cutting-edge capsule innovation, education, medical research, and development."

By unifying its brand, leveraging substantial investments in infrastructure, and continuing to innovate its product line, Lyfe Group is making a bold statement. The move signals a clear intent to not only maintain its leadership position but to redefine its role as a comprehensive solutions provider, ready to meet the complex challenges of the modern pharmaceutical and nutraceutical landscapes on a truly global scale.